Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Bristol Myers Squibb
BMY · NYSE · Pharmaceuticals
$59.56−1.79 (−2.92%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Bristol Myers Squibb (BMY) · oqro.io/stocks/BMY · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
A Bristol Myers Squibb director told the SEC about a plan to sell $250K of Bristol Myers Squibb shares around Nov 5, 2026. The shares were not acquired as compensation.
Since the trade +6.8% · S&P 500 +19.6% · to Nov 18
The CEO of Bristol Myers Squibb paid $110K out of pocket for Bristol Myers Squibb shares. 1 other person at Bristol Myers Squibb bought some too, in the same month.
Since the trade +10.5% · S&P 500 +19.8% · to Nov 18
Bristol Myers Squibb's Chief Med.Offr.,Drug Dev. paid $100K out of pocket for Bristol Myers Squibb shares. 1 other person at Bristol Myers Squibb bought some too, in the same month.
0 open-market purchases and 5 open-market sales by insiders of BMY between Jan 6, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 29, 2026. The data provider lists the next release for Feb 3, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Julia A Haller, Director, Nov 5, 2026, about $241K. Sold 7 days after the company's previous earnings release on 2026-10-29Form 4
Cristian Massacesi, EVP,Chief Med Offr,Head of Dev, Sep 9, 2026, about $403K. Sold 41 days after the company's previous earnings release on 2026-07-30Form 4
Phil M Holzer, SVP and Controller, Aug 25, 2026, about $34K. Sold 26 days after the company's previous earnings release on 2026-07-30Form 4
David V Elkins, EVP, Chief Financial Officer, Apr 1, 2026, about $1.57M. Sold 29 days before the company's next earnings release on 2026-04-30Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
David V Elkins, EVP, Chief Financial Officer, Apr 1, 2026, about $278K. Sold 29 days before the company's next earnings release on 2026-04-30